Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hylatopic plus
- Development stage
- Unknown
- Lead developer
- Encore Dermatology
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
Hylatopic Plus is a prescription topical emollient cream, lotion, or foam used to manage and relieve symptoms associated with various skin conditions such as atopic dermatitis (eczema), allergic contact dermatitis, radiation dermatitis, and other dry or irritated skin disorders. Its formulation includes key ingredients like sodium hyaluronate (a form of hyaluronic acid), ceramides (hydroxypropyl bispalmitamide MEA), dimethicone, theobroma grandiflorum seed butter, petrolatum, and natural free fatty acids. These components work synergistically to hydrate the skin by retaining moisture and restoring the protective barrier function of the epidermis. By maintaining a moist wound environment and supporting barrier repair, Hylatopic Plus helps alleviate burning, itching, pain, dryness, and scaling associated with dermatological conditions[5][6][7][10].
- Brand names
- Hylatopic PlusHylatopicPlus
- Other names
- Hylatopic Plus AurstatHylatopicplus Cream
02
Targets
Stratum corneum lipid barrier
Beyond the preview
Go deeper on hylatopic plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hylatopic plus.